Detail page

Knowledge Web

Person

Tjoung-Won Park-Simon

Ärztin

Name	Tjoung-Won Park-Simon
Place	Hannover (Wirkungsort) Deutschland
Gender	weiblich
Academic degree	Prof. Dr. med.
Profession	Ärztin (characteristic profession)
Variant	Tjoung-Won Park- Simon Tjoung Won Park-Simon
Related	Medizinische Hochschule Hannover Klinik für Frauenheilkunde und Geburtshilfe (Hannover) (Stellvertretende Klinikdirektorin)
Record type	Person
GND-Identifier	1102938580
Record ID	1102938580
Involved in show all Das metastasierte Mammakarzinom – ein Überblick zur Entwicklung der Therapiestandards 2024 Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease Palbociclib: Randomized Studies and Real-world Evidence as the Basis for Therapeutic Planning in Metastatic Breast Cancer Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024 Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024 A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers Two truncating variants in FANCC and breast cancer risk Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY Was ist gesichert in der Prävention, Diagnostik und Therapie des frühen Mammakarzinoms? Prognostische Faktoren bei Patientinnen mit Mammakarzinom und leptomeningealen Metastasen: eine Subanalyse des deutschen Registers für Hirnmetastasen beim Mammakarzinom – Versorgungsforschungspreis der DGS 2023 – eine Kurzübersicht AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2023 Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023 AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: update 2023 Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer : Update 2023 Arbeitsgemeinschaft Gynäkologische Onkologie recommendations for the diagnosis and treatment of patients with early breast cancer: update 2023 Common variants in breast cancer risk loci predispose to distinct tumor subtypes AGO-Empfehlungen zur operativen Therapie der Axilla nach neoadjuvanter Chemotherapie: Update 2021 AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022 AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022 Prevalence of deleterious germline variants in risk genes including \(BRCA1/2\) in consecutive ovarian cancer patients (AGO-TR-1) Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment Correction: AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update Prädiktoren der Inanspruchnahme und des Beginns einer onkologischen Rehabilitation nach Brustkrebs First Prospective Cross-Sectional Study on the Impact of Immigration Background and Education in Early Detection of Breast Cancer AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021 AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021 AGO Recommendations for the diagnosis and treatment of patients with early breast cancer: update 2021 AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer : update 2021 AGO recommendations for the surgical therapy of the axilla after neoadjuvant chemotherapy: 2021 Update AGO recommendations for the surgical therapy of the Axilla after neoadjuvant chemotherapy: 2021 update AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update Mendelian randomisation study of smoking exposure in relation to breast cancer risk Predicting prognosis of breast cancer patients with brain metastases in the BMBC registry - comparison of three different GPA prognostic scores Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores Prognose und Prädiktion bei nodalpositivem Mammakarzinom am Brustzentrum des Universitätsklinikums Halle an der Saale Germline variation of Ribonuclease H2 genes in ovarian cancer patients AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: update 2020 AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020 Characteristics and clinical outcome of breast cancer patients with asymptomatic brain metastases Identification of novel breast cancer susceptibility genes and first steps towards mutation-specific cell culture models Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer Klinischer Verlauf des zerebral metastasierten Mammakarzinoms in Abhängigkeit der Tumorbiologie Molecular investigations of triple-negative breast cancer : the role of mutations in CASP8 and FBXW8, and the cellular response to Alpelisib Assessment of an APOBEC3B truncating mutation, c.783delG, in patients with breast cancer Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1) Analysis of a RECQL splicing mutation, c.1667_1667+3delAGTA, in breast cancer patients and controls from Central Europe Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus Radiological patterns of brain metastases in breast cancer patients : a subproject of the german brain metastases in breast cancer (BMBC) registry The benefit of baseline staging : risk assessment of distant breast cancer metastases by tumor stage Mutation Analysis of the ERCC4/FANCQ Gene in Hereditary Breast Cancer Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe In vitro and in vivotherapeutic approach for a small cell carcinoma of the ovary hypercalcaemic type using a SCCOHT-1 cellular model Functional deficiency of NBN, the Nijmegen breakage syndrome protein, in a p.R215W mutant breast cancer cell line

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Tjoung-Won Park-Simon

Das metastasierte Mammakarzinom – ein Überblick zur Entwicklung der Therapiestandards 2024

Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease

Palbociclib: Randomized Studies and Real-world Evidence as the Basis for Therapeutic Planning in Metastatic Breast Cancer

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Two truncating variants in FANCC and breast cancer risk

Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY

Was ist gesichert in der Prävention, Diagnostik und Therapie des frühen Mammakarzinoms?

Prognostische Faktoren bei Patientinnen mit Mammakarzinom und leptomeningealen Metastasen: eine Subanalyse des deutschen Registers für Hirnmetastasen beim Mammakarzinom – Versorgungsforschungspreis der DGS 2023 – eine Kurzübersicht

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2023

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023

AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: update 2023

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer : Update 2023

Arbeitsgemeinschaft Gynäkologische Onkologie recommendations for the diagnosis and treatment of patients with early breast cancer: update 2023

Common variants in breast cancer risk loci predispose to distinct tumor subtypes

AGO-Empfehlungen zur operativen Therapie der Axilla nach neoadjuvanter Chemotherapie: Update 2021

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022

Prevalence of deleterious germline variants in risk genes including \(BRCA1/2\) in consecutive ovarian cancer patients (AGO-TR-1)

Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

Correction: AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update

AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update

Prädiktoren der Inanspruchnahme und des Beginns einer onkologischen Rehabilitation nach Brustkrebs

First Prospective Cross-Sectional Study on the Impact of Immigration Background and Education in Early Detection of Breast Cancer

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021

AGO Recommendations for the diagnosis and treatment of patients with early breast cancer: update 2021

AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer : update 2021

AGO recommendations for the surgical therapy of the axilla after neoadjuvant chemotherapy: 2021 Update

AGO recommendations for the surgical therapy of the Axilla after neoadjuvant chemotherapy: 2021 update

AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update

Mendelian randomisation study of smoking exposure in relation to breast cancer risk

Predicting prognosis of breast cancer patients with brain metastases in the BMBC registry - comparison of three different GPA prognostic scores

Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores

Prognose und Prädiktion bei nodalpositivem Mammakarzinom am Brustzentrum des Universitätsklinikums Halle an der Saale

Germline variation of Ribonuclease H2 genes in ovarian cancer patients

AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: update 2020

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020

Characteristics and clinical outcome of breast cancer patients with asymptomatic brain metastases

Identification of novel breast cancer susceptibility genes and first steps towards mutation-specific cell culture models

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study

Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer

Klinischer Verlauf des zerebral metastasierten Mammakarzinoms in Abhängigkeit der Tumorbiologie

Molecular investigations of triple-negative breast cancer : the role of mutations in CASP8 and FBXW8, and the cellular response to Alpelisib

Assessment of an APOBEC3B truncating mutation, c.783delG, in patients with breast cancer

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)

Analysis of a RECQL splicing mutation, c.1667_1667+3delAGTA, in breast cancer patients and controls from Central Europe

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

Radiological patterns of brain metastases in breast cancer patients : a subproject of the german brain metastases in breast cancer (BMBC) registry

The benefit of baseline staging : risk assessment of distant breast cancer metastases by tumor stage

Mutation Analysis of the ERCC4/FANCQ Gene in Hereditary Breast Cancer

Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe

In vitro and in vivotherapeutic approach for a small cell carcinoma of the ovary hypercalcaemic type using a SCCOHT-1 cellular model

Functional deficiency of NBN, the Nijmegen breakage syndrome protein, in a p.R215W mutant breast cancer cell line